|
1.
|
Clark JC, Akiyama T, Dass CR and Choong
PF: New clinically relevant, orthotopic mouse models of human
chondrosarcoma with spontaneous metastasis. Cancer Cell Int.
10:202010. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Hemmati M, Abbaspour A, Alizadeh AM, et
al: Rat xenograft chondrosarcoma development by human tissue
fragment. Exp Oncol. 33:52–54. 2011.PubMed/NCBI
|
|
3.
|
Li TM, Lin TY, Hsu SF, et al: The novel
benzimidazole derivative, MPTB, induces cell apoptosis in human
chondrosarcoma cells. Mol Carcinog. 50:791–803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bergh P, Gunterberg B, Meis-Kindblom JM
and Kindblom LG: Prognostic factors and outcome of pelvic, sacral,
and spinal chondrosarcomas: a center-based study of 69 cases.
Cancer. 91:1201–1212. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Fiorenza F, Abudu A, Grimer RJ, et al:
Risk factors for survival and local control in chondrosarcoma of
bone. J Bone Joint Surg Br. 84:93–99. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Bruns J, Elbracht M and Niggemeyer O:
Chondrosarcoma of bone: an oncological and functional follow-up
study. Ann Oncol. 12:859–864. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Qureshi A, Ahmad Z, Azam M and Idrees R:
Epidemiological data for common bone sarcomas. Asian Pac J Cancer
Prev. 11:393–395. 2010.PubMed/NCBI
|
|
8.
|
Gelderblom H, Hogendoorn PC, Dijkstra SD,
et al: The clinical approach towards chondrosarcoma. Oncologist.
13:320–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Ozaki T, Hillmann A, Lindner N, Blasius S
and Winkelmann W: Metastasis of chondrosarcoma. J Cancer Res Clin
Oncol. 122:625–628. 1996. View Article : Google Scholar
|
|
10.
|
Maibenco HC, Krehbiel RH and Nelson D:
Transplantable osteogenic tumor in the rat. Cancer Res. 27:362–366.
1967.PubMed/NCBI
|
|
11.
|
Stevens JW: Heterogeneity in growth
properties of the rat Swarm chondrosarcoma. Iowa Orthop J.
24:33–35. 2004.PubMed/NCBI
|
|
12.
|
Mason RM and Bansal MK: Different growth
rates of swarm chondrosarcoma in Lewis and Wistar rats correlate
with different thyroid hormone levels. Connect Tissue Res.
16:177–185. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Clark JC, Dass CR and Choong PF:
Development of chondrosarcoma animal models for assessment of
adjuvant therapy. ANZ J Surg. 79:327–336. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Folkman J: The role of angiogenesis in
tumor growth. Semin Cancer Biol. 3:65–71. 1992.
|
|
15.
|
Kenan S and Steiner GC: Experimental
transplantation of the Swarm rat chondrosarcoma into bone:
radiological and pathological studies. J Orthop Res. 9:445–451.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Grimaud E, Damiens C, Rousselle AV,
Passuti N, Heymann D and Gouin F: Bone remodelling and tumour grade
modifications induced by interactions between bone and swarm rat
chondrosarcoma. Histol Histopathol. 17:1103–1111. 2002.PubMed/NCBI
|
|
17.
|
Klenke FM, Abdollahi A, Bertl E, et al:
Tyrosine kinase inhibitor SU6668 represses chondrosarcoma growth
via antiangiogenesis in vivo. BMC Cancer. 7:492007. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Hamm CA, Stevens JW, Xie H, et al:
Microenvironment alters epigenetic and gene expression profiles in
Swarm rat chondrosarcoma tumors. BMC Cancer. 10:4712010. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Gouin F, Ory B, Redini F and Heymann D:
Zoledronic acid slows down rat primary chondrosarcoma development,
recurrent tumor progression after intralesional curretage and
increases overall survival. Int J Cancer. 119:980–984. 2006.
View Article : Google Scholar
|
|
20.
|
O’Neill K, Lyons SK, Gallagher WM, Curran
KM and Byrne AT: Bioluminescent imaging: a critical tool in
pre-clinical oncology research. J Pathol. 220:317–327.
2010.PubMed/NCBI
|
|
21.
|
Jenkins DE, Oei Y, Hornig YS, et al:
Bioluminescent imaging (BLI) to improve and refine traditional
murine models of tumor growth and metastasis. Clin Exp Metastasis.
20:733–744. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Comstock KE, Hall CL, Daignault S,
Mandlebaum SA, Yu C and Keller ET: A bioluminescent orthotopic
mouse model of human osteosarcoma that allows sensitive and rapid
evaluation of new therapeutic agents In vivo. In Vivo. 23:661–668.
2009.
|
|
23.
|
Honigman A, Zeira E, Ohana P, et al:
Imaging transgene expression in live animals. Mol Ther. 4:239–249.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Sarraf-Yazdi S, Mi J, Dewhirst MW and
Clary BM: Use of in vivo bioluminescence imaging to predict hepatic
tumor burden in mice. J Surg Res. 120:249–255. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Doyle TC, Burns SM and Contag CH: In vivo
bioluminescence imaging for integrated studies of infection. Cell
Microbiol. 6:303–317. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Liu R, Wolinsky JB, Catalano PJ, et al:
Paclitaxel-eluting polymer film reduces locoregional recurrence and
improves survival in a recurrent sarcoma model: a novel
investigational therapy. Ann Surg Oncol. 19:199–206. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Yonekawa M, Kondo S, Sugiura H, et al:
Serum cartilage-derived retinoic acid-sensitive protein (CD-RAP)
levels in swarm rat chondrosarcoma. J Orthop Res. 20:382–386. 2002.
View Article : Google Scholar : PubMed/NCBI
|
